US Drug Recall Register

FDA Drug Recalls

14,450 recalls · Class II, newest first

Class II · Moderate risk Terminated

Preferred Plus Pharmacy Antacid

Reason CGMP Deviations: Products are being recalled due to an out of specification total aerobic microbial count in a water sample.

RIJ Pharmaceutical LLC D-0843-2018
Class II · Moderate risk Terminated

Preferred Plus Pharmacy Antacid Extra Strength

Reason CGMP Deviations: Products are being recalled due to an out of specification total aerobic microbial count in a water sample.

RIJ Pharmaceutical LLC NDC 53807-158-12 D-0842-2018
Class II · Moderate risk Terminated

Hydrocortisone Ointment

Reason Failed Stability Specifications

Perrigo New York NDC 45802-014-02 D-0817-2018
Class II · Moderate risk Terminated

Minivelle

Reason Defective Delivery System: no longer meets the specification for shear, an attribute related to the adhesive properties of the transdermal patches. As a result, patients could experience patches that do not stick well to the skin.

Noven Pharmaceuticals, Inc. NDC 68968-6637-1 D-0863-2018
Class II · Moderate risk Terminated

Minivelle

Reason Defective Delivery System: no longer meets the specification for shear, an attribute related to the adhesive properties of the transdermal patches. As a result, patients could experience patches that do not stick well to the skin.

Noven Pharmaceuticals, Inc. NDC 68968-6610-1 D-0862-2018
Class II · Moderate risk Terminated

Naturmetic SPF 50 Sunscreen

Reason GMP Deviations

Milbar Laboratories, Inc. D-0813-2018
Class II · Moderate risk Terminated

B Prox 10 Anti-blemish Wash

Reason Microbial Contamination of Non-sterile Product

Milbar Laboratories, Inc. D-0811-2018
Class II · Moderate risk Terminated

Loxapine Capsules

Reason GMP Deviations: a recent FDA inspection of the manufacturing site revealed multiple cGMP violations that would place Loxapine at risk for cross contamination

Mylan Institutional, Inc. (d.b.a. UDL Laboratories) NDC 51079-903-20 D-0823-2018
Class II · Moderate risk Terminated

Loxapine Capsules

Reason GMP Deviations: a recent FDA inspection of the manufacturing site revealed multiple cGMP violations that would place Loxapine at risk for cross contamination

Mylan Institutional, Inc. (d.b.a. UDL Laboratories) NDC 51079-902-20 D-0822-2018
Class II · Moderate risk Terminated

Docetaxel injection concentrate

Reason Superpotent drug: over-concentrated vials of Docetaxel injection concentrate 20 mg/mL may have been distributed.

Sanofi-Aventis U.S. LLC NDC 0955-1020-01 D-0804-2018
Class II · Moderate risk Terminated

Macroaggregated albumin

Reason Lack of Assurance of Sterility

Coast Quality Pharmacy LLC D-0801-2018
Class II · Moderate risk Terminated

Loxapine Capsules

Reason CGMP Deviations

Mylan Pharmaceuticals Inc. NDC 0378-7050-01 D-0825-2018
Class II · Moderate risk Terminated

Loxapine Capsules

Reason CGMP Deviations

Mylan Pharmaceuticals Inc. NDC 0378-7025-01 D-0824-2018
Class II · Moderate risk Terminated

Amlodipine and Benazapril HCL Capsules

Reason cGMP Deviations; cleaning processes for equipment used to manufacture the specified batches was not followed according to procedure

Mylan Pharmaceuticals Inc. NDC 0378-6899-01 D-0820-2018
Class II · Moderate risk Terminated

Amlodipine and Benazapril HCL Capsules

Reason cGMP Deviations; cleaning process for equipment used to manufacture the specified batches was not followed according to procedure

Mylan Pharmaceuticals Inc. NDC 0378-6896-01 D-0819-2018
Class II · Moderate risk Terminated

Acetaminophen 300 mg with Codeine Phosphate 30 mg tablets

Reason Labeling: Not Elsewhere Classified: due to a labeled declaration of; Store at 15¿C to 30¿C (59¿F to 86¿F) which differs from the original manufacturer declaration of; Store at 20¿C to 25¿C (68¿F to 77¿F).

Prescript Pharmaceuticals, Inc. D-0809-2018
Class II · Moderate risk Terminated

Clindamycin 300 mg capsules

Reason Labeling: Not Elsewhere Classified: due to a labeled declaration of; Store at 15¿C to 30¿C (59¿F to 86¿F) which differs from the original manufacturer declaration of; Store at 20¿C to 25¿C (68¿F to 77¿F).

Prescript Pharmaceuticals, Inc. D-0808-2018
Class II · Moderate risk Terminated

Chlorhexidine 0.12% liquid

Reason Labeling: Not Elsewhere Classified: due to a labeled declaration of; Store at 15¿C to 30¿C (59¿F to 86¿F) which differs from the original manufacturer declaration of; Store at 20¿C to 25¿C (68¿F to 77¿F).

Prescript Pharmaceuticals, Inc. D-0807-2018
Class II · Moderate risk Terminated

Acetaminophen 300 mg with Codeine Phosphate 30 mg tablets

Reason Labeling: Not Elsewhere Classified: due to a labeled declaration of; Store at 15¿C to 30¿C (59¿F to 86¿F) which differs from the original manufacturer declaration of; Store at 20¿C to 25¿C (68¿F to 77¿F).

Prescript Pharmaceuticals, Inc. D-0806-2018
Class II · Moderate risk Terminated

Clindamycin 150 mg capsules

Reason Labeling: Not Elsewhere Classified: due to a labeled declaration of; Store at 15¿C to 30¿C (59¿F to 86¿F) which differs from the original manufacturer declaration of; Store at 20¿C to 25¿C (68¿F to 77¿F).

Prescript Pharmaceuticals, Inc. D-0805-2018